V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
Dodge & Cox Stock Fund 13F holdings
Dodge & Cox Stock Fund's Portfolio
- Portfolio value:
- $118.17B~
- # of securities:
- 90 (-1)
- Reported for:
- 30 Jun 2026 (Q2)
- Latest filing date:
- 28 Aug 2026
What stocks does Dodge & Cox Stock Fund own?
What is Dodge & Cox Stock Fund's portfolio?
Dodge & Cox Stock Fund has disclosed a total of 90 security holdings in their (2026 Q2) SEC filing(s) with portfolio value of $118,167,037,646.
Dodge & Cox Stock Fund's portfolio holdings are tracked quarterly based on SEC filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Dodge & Cox Stock Fund's original SEC reports (2026 Q2) are the official SEC institutional disclosure documents covering all reported equity positions.
86 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Charles Schwab Corp
|
4.01%
|
51,357,235
|
$92.27
|
+18.41%($109.26)
|
$4,738,732,073
|
2019 Q3
|
~7.00 years
|
|
|
|
|
|
RTX Corp
|
3.75%
|
23,368,900
|
$189.73
|
+9.20%($207.19)
|
$4,433,781,397
|
2019 Q3
|
~7.00 years
|
-3.12% (-753.1K)
|
-0.12%
|
|
|
|
TAIWAN SEMICONDUCTOR MANUFAC
|
3.55%
|
54,567,700
|
$76.79
|
|
$4,190,179,762
|
2025 Q1
|
~1.50 years
|
+7.70% (+3.9M)
|
+0.25%
|
|
|
|
Johnson Controls International PLC
|
3.28%
|
26,516,117
|
$146.11
|
-5.50%($138.08)
|
$3,874,269,855
|
2019 Q3
|
~7.00 years
|
-5.90% (-1.66M)
|
-0.21%
|
|
|
|
CVS Health Corp
|
2.78%
|
31,708,094
|
$103.45
|
-5.91%($97.34)
|
$3,280,202,324
|
2019 Q3
|
~7.00 years
|
-6.43% (-2.18M)
|
-0.2%
|
|
|
|
Microsoft Corp
|
2.52%
|
7,995,900
|
$373.02
|
+34.98%($503.49)
|
$2,982,630,618
|
2019 Q3
|
~7.00 years
|
+4.47% (+342K)
|
+0.11%
|
|
|
|
Alphabet Inc, CL-A
|
2.52%
|
8,335,300
|
$357.37
|
-5.90%($336.28)
|
$2,978,786,161
|
2019 Q3
|
~7.00 years
|
|
|
|
|
|
MetLife Inc
|
2.48%
|
34,628,342
|
$84.61
|
+12.17%($94.91)
|
$2,929,904,017
|
2019 Q3
|
~7.00 years
|
-7.90% (-2.97M)
|
-0.22%
|
|
|
|
Humana Inc
|
2.47%
|
7,354,500
|
$397.22
|
-0.26%($396.20)
|
$2,921,354,490
|
2024 Q2
|
~2.25 years
|
-2.61% (-197K)
|
-0.07%
|
|
|
|
Amazon.com Inc
|
2.17%
|
10,757,900
|
$238.34
|
+6.88%($254.73)
|
$2,564,037,886
|
2022 Q3
|
~4.00 years
|
+10.33% (+1.01M)
|
+0.2%
|
|
Completely sold out
7 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
LyondellBasell Industries NV
|
-11,197,363
|
-0.79%
|
2020 Q2
|
~6.00 years
|
|
|
|
Goldman Sachs Group Inc
|
-1,000,400
|
-0.74%
|
2019 Q3
|
~6.75 years
|
|
|
|
Novartis AG ADR
|
-5,087,508
|
-0.68%
|
2019 Q3
|
~6.75 years
|
|
|
|
Roche Holding Ltd ADR
|
-12,947,699
|
-0.56%
|
2019 Q3
|
~6.75 years
|
|
|
|
State Street Corp
|
-2,682,300
|
-0.3%
|
2019 Q4
|
~6.50 years
|
|
|
|
Bristol-Myers Squibb Company
|
-3,201,639
|
-0.17%
|
2019 Q3
|
~6.75 years
|
|
|
|
GE Aerospace
|
-222,538
|
-0.06%
|
2022 Q1
|
~4.25 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".
* % of portfolio: the total can exceed 100%, e.g. when there are also options positions, which can be short.